BioSpace News Archive

Repare Therapeutics Inc., a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, announced that members of its senior management team will participate in two virtual investor conferences in February.

Regio Biosciences (Regio), a Hibiscus BioVentures company, announced today it has entered into an exclusive license agreement with AstraZeneca to further develop REG-101, a novel therapeutic acting on reverse cholesterol transport (RCT).

LinKinVax, a clinical-stage biotech company, is announcing the signing of an exclusive worldwide licensing agreement with Inserm Transfert to develop a vaccine strategy with an innovative mechanism of action.

Rewrite Therapeutics’ proprietary and versatile DNA writing platform enables a range of novel genome editing strategies.

Quipt Home Medical Corp. announced today that Mr. Brian J. Wessel has joined the Board of Directors of the Company as an Independent Director and Chair of the Audit Committee.

iSpecimen Inc. today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2021, before the markets open on Thursday, February 17, 2022.

Third Pole Therapeutics announced today that it has achieved several significant milestones that include closing a $25M round of financing, and that eNOfit™, the Company’s fully miniaturized wearable device, is ready for clinical trials.

Surmodics, Inc. today announced results for its fiscal 2022 first quarter ended December 31, 2021.

Akoya Biosciences, Inc., The Spatial Biology Company®, announced that it will be virtually participating in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference.

Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that Jonathan Drachman, M.D., Chief Executive Officer, will participate in a fireside chat at the Guggenheim Healthcare Oncology Talks 2022 Oncology Conference.